Article
TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer
1 Dec 2013
Abstract excerpt
BACKGROUND: In our previous study using oligonucleotide microarrays, we revealed that transglutaminase 3 (TGM3) was remarkably down-regulated in head and neck cancer (HNC). However, the potential of TGM3 as a useful biomarker or molecular target for HNC is unclear. METHODS: The transcriptional and post-translational status of TGM3 in HNC cell lines and specimens was detected using real-time PCR and western blot...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
